Accès ouvert
2023
article
OpenAlex
Jacqueline A. French, Roger J. Porter, Emilio Perucca, Martin J. Brodie et autres
Importance: Many patients with focal epilepsy experience seizures despite treatment with currently available antiseizure medications (ASMs) and may benefit from novel therapeutics. Objective: To evaluate the efficacy and safety of XEN1101, a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener, in the treatment …
us, au, gb, ca
(code pays fourni par la source)
2023
article
OpenAlex
Hina Dave, Jacqueline A. French, Heidi Henninger, Hamada Altalib et autres
Objective: Examine the relationship between baseline seizure control as well as clinical characteristics and outcomes on brivaracetam (BRV). Background: EP0088 (Dave H, et al. AES 2021; abstract 2.203) assessed clinical utility of BRV by examining 6- and 12-month retention after BRV initiation …
us, au, be
(code pays fourni par la source)
2022
article
OpenAlex
Hamada Altalib, Jacqueline A. French, Michael R. Sperling, Heidi Henninger et autres
Measure patient perception of change in mood/fatigue/sleep disturbance/disability during brivaracetam (BRV) treatment using patient-reported outcomes (PROs): validated PRO Measurement Information System (PROMIS), new Seizure-Related Disability Assessment Scale (SERDAS).
us, au, be
(code pays fourni par la source)
2022
article
OpenAlex
Hina Dave, Jacqueline A. French, Hamada Altalib, Heidi Henninger et autres
To assess effectiveness of adjunctive brivaracetam (BRV) in adults with focal seizures as measured by retention.
us, au, be
(code pays fourni par la source)
2022
article
OpenAlex
Heidi Henninger, Michael R. Sperling, Hamada Altalib, Hina Dave et autres
Assess long-term real-world effectiveness and tolerability of brivaracetam (BRV) in adults with focal seizures by reason for BRV initiation.
us, be, au
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Nicholas Streltzov, Samantha Schmidt, Lindsay Schommer, Wenyan Zhao et autres
BACKGROUND AND OBJECTIVES: We conducted a multisite, pragmatic replication trial at 4 New England epilepsy centers to determine the effectiveness of Home-Based Self-Management and Cognitive Training Changes Lives (HOBSCOTCH) in a real-world setting and to assess feasibility of a virtual intervention. METHODS: …
us
(code pays fourni par la source)
2020
article
OpenAlex
Kaitlin Taplinger, Lauren Manning, Heidi Henninger
us
(code pays fourni par la source)
2020
article
OpenAlex
Nicholas Streltzov, Samantha Schmidt, Wenyan Zhao, Lindsay Schommer et autres
To assess the longitudinal effects of the HOBSCOTCH epilepsy self-management program.
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Robert J. Quon, Angeline S. Andrew, Samantha Schmidt, Cam Escoffery et autres
us
(code pays fourni par la source)
2019
article
OpenAlex
Samantha Schmidt, Wenyan Zhao, Robert M. Roth, Lindsay Schommer et autres
To expand implementation and replicate results of HOBSCOTCH—an innovative telephone based self-management program addressing memory problems in epilepsy.
us
(code pays fourni par la source)
2018
article
OpenAlex
Heidi Henninger, Jane G. Morris, Diana Goodman, Barbara C. Jobst
N/A
us
(code pays fourni par la source)
2017
article
OpenAlex
Nicholas Streltzov, Samantha Schimdt, Wenyan Zhao, Robert M. Roth et autres
An interim analysis from the replication trial of the epilepsy self-management program, HOme Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) performed at four epilepsy centers in Northern New England.
us
(code pays fourni par la source)